Lennon David James's Form 4 filing
Whitehawk Therapeutics, Inc. (WHWK) · filed Apr 3, 2026
- Accession no.
- 0001995275-26-000006
- Filed
- Apr 3, 2026
- Trade date
- Apr 1-2, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $93.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lennon David JamesCIK 0001995275 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | MOption exerciseAcquired | +775,828 | –F1 | – | 820,407 | Direct | |
| Apr 2, 2026 | Common Stock | SSaleDisposed | −26,858 | $3.48 | −$93,465.84 | 793,549 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | MOption exerciseDisposed | −775,828 | $0.00 | $0 | 0 | Direct | |
| Apr 1, 2026 | Common Stock | AGrant or awardAcquired | +831,148 | $0.00 | $0 | 831,148 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
Referenced by the price of 1 transaction in Table I.